There will be no buy out. So no worries... Nader b
Post# of 151830
We will soon all get aboard the approval train and start knocking out approvals by the handful each year. If you remember the Cytodyn Board of Director’s goals were set at 10 indications a year for new trials. With choosing saving lives as the indications that get trialed first. Those just happen to be the highest return indications also. Saving lives is big money.
Then we will all be happy that we stayed in CYDY for the long term. I still want to believe what our CEO Nader said “ this stock could be a high triple digit stock or even a quadruple digit stock some day. I am hoping some day is only 3-5 years with the blockbuster indications we will be chasing. If we are approved on the top 10 indications Leronlimab has been speculated to work for. Then it’s easy to see a $1,000/share stock price. That’s the dream people. Let’s not lose sight of what could happen. Let’s just hope that all the signs that have pointed us here will fill our dreams with everything we hope to be true. Today we get a current map of our predicted progress for 2021 in the conference call. It’s going to be a blockbuster year in my opinion. Every day we are getting closer. Our day is coming soon. Approve Leronlimab now... save lives now...

